Glioblastoma (GBM) is one of the most aggressive forms of human brain cancer, which kills thousands of patients within a year. Tumor cells develop resistance to the treatments, making them ineffective.
Aug 5, 2019, scientists from Brain Tumor Research Center of University of Portsmouth showed a combination of three regular ingredients, called P1867B, worked with existing cancer treatments boosting their effectiveness and, in some cases, restored sensitivity to some treatments.
In a mice model, P1867B worked to reduce the size of Glioblastoma. P1867B is a combination of aspirin, triacetin and saccharin, all of which are common.
The next step is to run the first trial i n humen.